Risk Factors of ICU-acquired Weakness
ICU-AW
ICU-acquired Weakness in Extracorporeal Membrane Oxygenation Support: Frequency and Risk Factors
1 other identifier
observational
85
1 country
1
Brief Summary
We conducted a retrospective study of critical ill patients who used ECMO during their ICU stay. ICU-AW was diagnosed at the time when patients discharged and had a Medical Research Council (MRC) sum score \< 48 out of a maximal score of 60. We divided patients to ICU-acquired weakness group and no ICU-acquired weakness group and compared their clinical characteristics. Baseline characteristics and therapy details were collected from the case report forms and inspection reports. Univariable analysis and logistic regression analysis were used to analyze clinical characteristics of individuals and to find risk factors of ICU-AW.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 1, 2021
CompletedFirst Posted
Study publicly available on registry
June 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedJune 21, 2021
June 1, 2021
3 years
June 1, 2021
June 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences between ICU-acquired weakness in patients receiving extracorporeal membrane oxygenation support
We compared the clinical characteristics between ICU-acquired weakness group and no ICU-acquired weakness group by univariate analysis . Then we used logistic regression analysis and found out differences of ICU-acquired weakness.
1 day
Secondary Outcomes (1)
Frequency of ICU-acquired weakness in in patients receiving extracorporeal membrane oxygenation support
1 day
Study Arms (2)
ICU-acquired weakness group
Patients receiving extracorporeal membrane oxygenation support who had a Medical Research Council (MRC) sum score \< 48 out of a maximal score of 60 when discharged.
no ICU-acquired weakness group
Patients receiving extracorporeal membrane oxygenation support who had a Medical Research Council (MRC) sum score ≥ 48 out of a maximal score of 60 when discharged.
Eligibility Criteria
There were 85 patients used extracorporeal membrane oxygenationbetween March 2017 to March 2020. Among the 85 patients, 22 patients presented exclusion criteria and 63 patients were included in the final analysis.
You may qualify if:
- Critical ill patients who used extracorporeal membrane oxygenation during their ICU stay. Patients were recruited from the general ICU of the second affiliated hospital of Zhejiang University, between March 2017 to March 2020.
You may not qualify if:
- Patients who was less than 18 years old, had been proven or suspected neurological impairment, using extracorporeal membrane oxygenation less than 24 hours, severe head or spinal cord injury and pregnant woman.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xinyi Chen
Hangzhou, Please Select, 310000, China
Central Study Contacts
man huang, phD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2021
First Posted
June 21, 2021
Study Start
March 1, 2017
Primary Completion
March 1, 2020
Study Completion
June 1, 2022
Last Updated
June 21, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
One year after the article was published, and the opening lasted for one year